South London and Maudsley NHS Foundation Trust: FY1819 Q2 Performance in Initiating

Size: px
Start display at page:

Download "South London and Maudsley NHS Foundation Trust: FY1819 Q2 Performance in Initiating"

Transcription

1 of First 17/YH/ /YH/ /LO/ /LO/ /WM/ /LO/ A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Second Generation Antipsychotics in Subjects With Stable Schizophrenia A Phase 2 Randomized, Investigator- Blind, Placebo-Controlled, Cross-Over Study to Evaluate Pharmacodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of TAK-831 in Adult Subjects With Schizophrenia A feasibility study and pilot trial of a modified video-feedback intervention for children and foster carers to improve mental health outcomes of children with reactive attachment problems A feasibility study of Acceptance and Commitment Therapy for older people with treatment-resistant generalised anxiety disorder (FACTOID) A randomised controlled clinical trial of therapist-assisted online psychological therapies for post-traumatic stress disorder (STOP-PTSD) An investigation into social information processing in adolescents with eating disorders: Implications for theory and clinical practice 01/11/ /10/ /08/ /10/ /11/ /11/ /03/2018 Neither 01/11/ /10/ /11/ /10/ /11/ /10/ /02/2018 Neither 06/10/ /10/ /08/ /03/ /03/ /03/ /08/2018 Sponsor 18/07/ /11/ /09/ /12/ /12/ /12/ /01/2018 Sponsor 16/11/ /11/ /01/ /01/ /01/ /01/ /03/2018 NHS Provider 26/09/ /12/ /12/ /03/ /03/ /03/ /05/2018 Sponsor 1

2 of First 17/LO/ /LO/ /LO/ /LO/ fmri Neurofeedback as a novel neurotherapy for children with ADHD Monitoring quality of dementia care - preliminary evaluation of the MABLE interface for automated evaluation of caregiver interactions A phase II randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety,and tolerability of orally administered BI during a 52-week treatment period for the prevention of firstepisode of psychosis in subjects with attenuated psychosis syndrome. Use of blue blocking glasses in mania: a feasibility study 21/07/ /12/ /12/ /01/ /01/ /01/ /02/2018 Please Select... 15/09/ /10/ /02/ /03/ /03/ /03/ /06/2018 Neither 17/10/ /01/ /12/ /01/ /02/ /07/2018 Both 02/10/ /01/ /01/ /01/ /01/ /01/ /07/2018 Sponsor 17/LO/ Psychiatric Nursing Observation at night: a single case experimental design (SCED) 17/10/ /11/ /11/ /01/ /01/ /01/ /05/2018 Both 17/LO/ Testing The Feasibility And Acceptability Of A New Personalised Form Of Cognitive Remediation Therapy (pcrt) For People With Psychosis 25/10/ /01/ /01/ /02/ /02/ /02/ /09/2018 Sponsor 18/LO/ COMPASS Study: A study to examine the use of Virtual Reality (VR) to enhance self-compassion and motivation in a group of patients with Anorexia Nervosa. 20/12/ /02/ /02/ /05/ /05/ /05/ /05/2018 Sponsor 2

3 of First 18/LO/ Feasibility and acceptability of a randomised controlled trial of an integrated group intervention to reduce intimate partner violence perpetration among men receiving treatment for substance use 01/03/ /03/ /04/ /05/ /05/ /05/ /07/2018 Sponsor 18/SC/ EFFIP (E-support for Families and Friends of Individuals affected by Psychosis): A randomised controlled trial of a coproduced online intervention for carers 07/02/ /03/ /02/ /03/ /03/ /03/ /03/2018 Please Select... 18/LO/ /SC/ Evaluating the feasibility and acceptability of a novel mobile intervention targeting social cognition in individuals with psychosis. Interventional, randomised, double-blind, active-controlled study on the efficacy of Lu AF35700 in patients with early-indisease or late-in-disease treatment resistant schizophrenia 26/02/ /04/ /06/ /07/ /07/ /07/ /08/2018 Sponsor 19/01/ /03/ /01/ /04/ /04/ /04/ /06/2018 Neither 18/LO/ /LO/ A Multicentre, 8-week, Single-arm, Openlabel, Pragmatic Trial to Explore Acceptance and Performance of Using a Digital Medicine with Healthcare Professionals and Adult Subjects with Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic (Aripiprazole, Olanzapine, Quetiapine, or Risperidone) Can imagination change upsetting memories of trauma? 18/04/ /04/ /03/ /06/ /06/ /06/2018 Sponsor 22/03/ /05/ /05/ /07/ /07/ /07/ /08/2018 NHS Provider 3

4 of First 18/LO/ /LO/ /YH/ /WA/ /LO/ The Early Youth Engagement in first episode psychosis (EYE-2) study: pragmatic cluster randomised controlled trial of implementation, effectiveness & cost effectiveness of a team-based motivational engagement intervention to improve engagement Craving Induction and Imagery-based Coping for Cocaine Use Disorder: Clinical Study A randomized, double-blind, placebocontrolled, two-cohort parallel group study to evaluate the efficacy of CAD106 and CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer s disease A Phase 3, multicenter, randomized, double-blind, placebocontrolled, paralleldesign study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6- DM]/ quinidine sulfate [Q]) for the treatment of agitation in patients with dementia of the Alzheimer s type. A Validation Study of a computerized, Artificial Intelligence assisted cognitive assessment test compared to a widely used cognitive assessment test and specialist clinical diagnosis in patients with Alzheimer s Dementia and Mild Cognitive Impairment 14/05/ /05/ /05/ /10/ /10/ /10/2018 Sponsor 16/05/ /07/ /07/ /09/ /09/ /09/2018 Both 29/08/ /08/ /11/ /08/ /08/ /08/2018 Neither 25/04/ /07/ /07/ /07/ /08/ /08/2018 Neither 15/06/ /08/ /06/ /08/ /09/ /09/2018 Please Select... 4

5 of First 18/EE/ A Placebo-Controlled, Double-Blind, Parallel-Group, Randomized, Study To Evaluate the Efficacy, Safety and Tolerability of E2027 in Subjects With Dementia With Lewy Bodies (DELPHIA) 24/07/ /09/ /07/ /09/ /10/ /10/2018 Please Select... 18/LO/ The Safety and Efficacy of Psilocybin in s with Treatment-Resistant Depression (P-TRD) 24/07/ /07/ /07/ /08/ /08/ /08/2018 NHS Provider 18/LO/ A Global PRospective, Multi-cEnter, ObServational post-market Study to assess short, mid and long-term Effectiveness and efficiency of VNS Therapy as adjunctive therapy in realworld patients with difficult to treat depression. 14/05/ /09/ /06/ /09/ /09/ /09/2018 Please Select... 18/LO/ The Effects of Psilocybin on Cognitive Function in Healthy s 24/07/ /07/ /07/ /08/ /08/ /08/2018 Please Select... 5

South London and Maudsley NHS Foundation Trust: FY1718 Q4 Performance in Initiating

South London and Maudsley NHS Foundation Trust: FY1718 Q4 Performance in Initiating 17/SC/0095 205780 Glutamatergic Medication in the Treatment of Obsessive-Compulsive Disorder (OCD) and Autism Spectrum Disorder (ASD) of First 07/02/2017 06/06/2017 22/06/2017 17/LO/1093 221300 A couple-based

More information

Performance of Initiating Q South London and Maudsley NHS Foundation Trust:

Performance of Initiating Q South London and Maudsley NHS Foundation Trust: By of First 16/LO/1439 212222 16/EE/0318 201898 16/LO/0873 193362 16/EE/0233 188916 16/LO/1862 206680 A pilot study of two sessions responsibility intervention for auditory hallucinations A randomised

More information

Performance of Initiating Q South London and Maudsley NHS Foundation Trust:

Performance of Initiating Q South London and Maudsley NHS Foundation Trust: 16/LO/1102 177307 The Role of Nitric Oxide in Cognition in Schizophrenia: the NOC study 06/03/2017 22/04/2016 15/08/2016 15/08/2016 08/09/2016 08/09/2016 08/09/2016 Neither 16/LO/1299 200774 The development

More information

Performance of Initiating Q South London and Maudsley NHS Foundation Trust:

Performance of Initiating Q South London and Maudsley NHS Foundation Trust: Research Ethics Committee Reference Number Integrated Research Application System Number Submission Type Name of Trial Date of Receipt of Valid Research Application Date of NHS First Patient Recruited?

More information

CURRICULUM VITAE. Andrea Marraffino, Ph.D.

CURRICULUM VITAE. Andrea Marraffino, Ph.D. CURRICULUM VITAE CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Site Liaison Tel. (866) 669-0234 Fax (208) 575-3169 Email: clinicaltrials@btheodore.com AFFILIATIONS: Florida Clinical

More information

Mental Health Current Articles Bulletin - April 2018

Mental Health Current Articles Bulletin - April 2018 Library and Knowledge Services Mental Health Current Articles Bulletin - April 2018 How to Obtain an Article If you would like to request any articles included in this bulletin, or to be put onto the bulletin

More information

Curriculum Vitae, David P. Walling, Ph.D. David P. Walling, Ph.D. Collaborative Neuroscience Network, LLC

Curriculum Vitae, David P. Walling, Ph.D. David P. Walling, Ph.D. Collaborative Neuroscience Network, LLC CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Alliance Director Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com AFFILIATIONS: Collaborative Neuroscience

More information

Curriculum Vitae, Lara Goenjian Shirikjian, D.O. Lara Goenjian Shirikjian, D.O. Collaborative Neuroscience Network, LLC

Curriculum Vitae, Lara Goenjian Shirikjian, D.O. Lara Goenjian Shirikjian, D.O. Collaborative Neuroscience Network, LLC CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Alliance Director Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com AFFILIATIONS: Collaborative Neuroscience

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release

More information

Curriculum Vitae, Michael J. Downing, M.D.

Curriculum Vitae, Michael J. Downing, M.D. CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Alliance Director Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com PROFESSIONAL AFFILIATIONS: Michael

More information

INDEX. P. 2 Provisional List of Potentially Harmful Therapies (Adapted from Lilienfeld, 2007)

INDEX. P. 2 Provisional List of Potentially Harmful Therapies (Adapted from Lilienfeld, 2007) Comprehensive List of Currently-Identified Potentially Harmful (PHTs) and Empirically Supported Psychological Treatments (ESTs) for Adults, Adolescents, and Children INDEX P. 2 Provisional List of Potentially

More information

Perfomance in Delivering (Commercial Trials)

Perfomance in Delivering (Commercial Trials) Perfomance in Delivering (Commercial Trials) REC Ref IRAS ID Name of Trial Target Of? Minimum Of Maximum Of Target Date To Recruit? Total Date Of to recruit target number Recruited At of patients The Target

More information

Hospital Authority Convention -- Development of an Integrated Service in the Management of Childhood and Adolescent Depression in Hong Kong

Hospital Authority Convention -- Development of an Integrated Service in the Management of Childhood and Adolescent Depression in Hong Kong Hospital Authority Convention -- Development of an Integrated Service in the Management of Childhood and Adolescent Depression in Hong Kong Dr. Tam Fung Ling Associate Consultant CAP, Castle Peak Hospital

More information

Jennifer M. Lytle, M.D., M.P.H. Clinical Trials of the Rockies 3955 E. Exposition Avenue, Suite 100 Denver, CO Tel.

Jennifer M. Lytle, M.D., M.P.H. Clinical Trials of the Rockies 3955 E. Exposition Avenue, Suite 100 Denver, CO Tel. CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Site Liaison Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com EDUCATION: Jennifer M. Lytle, M.D., M.P.H.

More information

Prescribing medications for people with a personality disorder A service evaluation of a community mental health team

Prescribing medications for people with a personality disorder A service evaluation of a community mental health team Prescribing medications for people with a personality disorder A service evaluation of a community mental health team Dr Umama Khan, Consultant Psychiatrist Dr Venkatesh Ballagere, Specialist Registrar

More information

New learning techniques in adults recruited from Memory Assessment Service clinics:

New learning techniques in adults recruited from Memory Assessment Service clinics: Studies for people with dementia SYMBAD: Study of Mirtazapine and Carbamazepine for Agitation in Dementia We are carrying out a research project to find out about the best way to help people who have agitation

More information

Resubmission. Scottish Medicines Consortium

Resubmission. Scottish Medicines Consortium Scottish Medicines Consortium Resubmission aripiprazole 5mg, 10mg, 15mg, 0mg tablets; 10mg, 15mg orodispersible tablets; 1mg/mL oral solution (Abilify ) No. (498/08) Bristol-Myers Squibb Pharmaceuticals

More information

Curriculum Vitae, Carmen Zegarra, M.D. Carmen Zegarra, M.D. FutureSearch Clinical Trials, L.P Parkcrest Drive, Suite 300 Austin, TX 78731

Curriculum Vitae, Carmen Zegarra, M.D. Carmen Zegarra, M.D. FutureSearch Clinical Trials, L.P Parkcrest Drive, Suite 300 Austin, TX 78731 CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Site Liaison Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com AFFILIATIONS: Carmen Zegarra, M.D. FutureSearch

More information

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA Disclosure Speaker Bureaus Pfizer Forest Norvartis Grant Support Pan American Health Organization/WHO NIA HRSA How Common is Psychosis in Alzheimer s Disease? Review of 55 studies 41% of those with Alzheimer

More information

The Pennine Acute Hospitals NHS Trust Performance in initiating clinical research Reporting period 1 October 2017 to 30 September 2018

The Pennine Acute Hospitals NHS Trust Performance in initiating clinical research Reporting period 1 October 2017 to 30 September 2018 The Pennine Acute Hospitals NHS Trust Performance in initiating clinical research Reporting period 1 October 2017 to 30 September 2018 REC reference IRAS reference Name of trial First patient recruited?

More information

The Pennine Acute Hospitals NHS Trust Performance in delivering clinical research Reporting period 1 October 2017 to 30 September 2018

The Pennine Acute Hospitals NHS Trust Performance in delivering clinical research Reporting period 1 October 2017 to 30 September 2018 The Pennine Acute Hospitals NHS Trust Performance in delivering clinical research Reporting period 1 October 2017 to 30 September 2018 REC reference IRAS reference Name of trial Target number of? Minimum

More information

Assessment and management of selfharm

Assessment and management of selfharm Assessment and management of selfharm procedure Version: 1.1 Consultation Approved by: Medical Director, CAMHS Director, Director of Quality, Patient Experience and Adult services Medical Director Date

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,

More information

FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality

FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality April 23, 2014 Pensacola, FL Presentation Objectives To briefly describe the program and how its components

More information

Geodon for anxiety and depression

Geodon for anxiety and depression When drugs like carbamazepine or cisapride are taken with Geodon, drug interactions can potentially occur. This emedtv page lists other drugs that may lead to Geodon. 8-2-2017 Find a comprehensive guide

More information

Platforms for Performance: Clinical Dashboards to Improve Quality and Safety 2011 Midyear Clinical Meeting

Platforms for Performance: Clinical Dashboards to Improve Quality and Safety 2011 Midyear Clinical Meeting Improving Mental Health Outcomes in Veterans Through Dashboard Technology Learning Objectives 1. Describe VA Academic Detailing 2. Show how an increase in metabolic monitoring and a decrease in off-label

More information

Clinical Psychopharmacology Made Ridiculously Simple (8th Edition)

Clinical Psychopharmacology Made Ridiculously Simple (8th Edition) Questions from chapter 2 Clinical Psychopharmacology Made Ridiculously Simple (8th Edition) 1) The emotional reaction which stems from a relatively minor event is a) grief b) anhedonia c) dysthymia d)

More information

EARLY ONSET SCHIZOPHRENIA

EARLY ONSET SCHIZOPHRENIA Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences EARLY ONSET SCHIZOPHRENIA JON MCCLELLAN CHILD STUDY AND TREATMENT CENTER GENERAL DISCLOSURES The University of Washington

More information

Amy Edmondson Mulroy, MD

Amy Edmondson Mulroy, MD Curriculum Vitae Amy Edmondson Mulroy, MD 7940 Floyd Curl Drive, Suite 700 7940 Floyd Curl Drive, Suite 1020 San Antonio, Texas 78229 San Antonio, Texas 78229 EDUCATION 1997 General Adult Psychiatry Internship

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 43 Effective Health Care Program Off-Label Use of Atypical Antipsychotics: An Update Executive Summary Background Antipsychotics medications are approved by the

More information

Psychotropic Medication. Including Role of Gradual Dose Reductions

Psychotropic Medication. Including Role of Gradual Dose Reductions Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which

More information

Slide 1. Slide 2. Slide 3. Risperidone Binding Profile. Risperidone Prescribing Facts. Risperidone Prescribing Facts

Slide 1. Slide 2. Slide 3. Risperidone Binding Profile. Risperidone Prescribing Facts. Risperidone Prescribing Facts Slide 1 Risperidone Binding Profile (high affinity for D2 receptors) a 1 antagonist a 2 antagonist Slide 2 Risperidone Prescribing Facts 2 8 mg/day for acute psychosis and bipolar disorder 0.5-2 mg /day

More information

Lithium in bipolar disorders.

Lithium in bipolar disorders. Lithium in bipolar disorders. S. Mehdi Samimi Ardestani M.D. Department of Psychiatry, Shahid Beheshti University of Medical Science, Behavioral science research center Iranian psychiatric association,

More information

2013 Virtual AD/HD Conference 1

2013 Virtual AD/HD Conference 1 Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com

More information

Mood Disorders and Addictions: A shared biology?

Mood Disorders and Addictions: A shared biology? Mood Disorders and Addictions: A shared biology? Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Disclosures No relevant disclosures: No paid

More information

Current Research All studies are approved by an NHS Research Ethics Committee and by the Trust.

Current Research All studies are approved by an NHS Research Ethics Committee and by the Trust. Current Research Please see the list below of active research studies which are taking place at Greater Manchester West Mental Health NHS Foundation Trust: Research is needed to improve and develop mental

More information

Managing agitation in dementia using non-pharmacological therapies

Managing agitation in dementia using non-pharmacological therapies Managing agitation in dementia using non-pharmacological therapies Gill Livingston Lynsey Kelly, Elanor Lewis-Holmes, Gianluca Baio, Rumana Omar, Stephen Morris, Nishma Patel, Cornelius Katona, Claudia

More information

Technology appraisal guidance Published: 24 July 2013 nice.org.uk/guidance/ta292

Technology appraisal guidance Published: 24 July 2013 nice.org.uk/guidance/ta292 Aripiprazole for treating moderate to severe ere manic episodes in adolescents with bipolar I disorder Technology appraisal guidance Published: 24 July 2013 nice.org.uk/guidance/ta292 NICE 2018. All rights

More information

CV for Dr Claire Wilson

CV for Dr Claire Wilson Yorkshire Psychology Practice, Trauma and Rehabilitation Service CV for Dr Claire Wilson BSc Hons (First Class), Doctorate in Clinical Psychology, CPsychol. PROFESSIONAL QUALIFICATIONS & EXPERTISE Professional

More information

Society for Prevention Research 2018 Call for Papers Author Abstract Submission Questions. Research Foci

Society for Prevention Research 2018 Call for Papers Author Abstract Submission Questions. Research Foci Society for Prevention Research 2018 Call for Papers Author Abstract Submission Questions Research Foci Please select your Research Foci. (Select all that apply) Academic Achievement ADHD Addiction Aging

More information

Resources for Carers Additional information resources

Resources for Carers Additional information resources Resources for Carers Additional information resources 1 2 The publications listed in this booklet can provide you with additional information about the person you are caring for. If you would like a copy

More information

Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics

Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics John Donoghue Liverpool L imagination est plus important que le savoir Albert Einstein Switching Antipsychotics: Objectives

More information

9/16/2016. I would feel comfortable dispensing/prescribing varenicline to a patient with a mental health disorder. Learning Objectives

9/16/2016. I would feel comfortable dispensing/prescribing varenicline to a patient with a mental health disorder. Learning Objectives The Smoking Gun: for Smoking Cessation in Patients with Mental Health Disorders BRENDON HOGAN, PHARMD PGY2 PSYCHIATRIC PHARMACY RESIDENT CTVHCS, TEMPLE, TX 09/23/2016 I would feel comfortable dispensing/prescribing

More information

Curriculum Vitae, Conrad O. Beckles, M.S., L.M.H.C., Ph.D.

Curriculum Vitae, Conrad O. Beckles, M.S., L.M.H.C., Ph.D. CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Alliance Director Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com AFFILIATIONS: Conrado Oscar Beckles,

More information

Managing challenging behaviours

Managing challenging behaviours Managing challenging behaviours Aims: Explore a selected psychosocial approach that may help to reduce the use of medication The positive and negative aspects of using the Newcastle model Look at how Newcastle

More information

Mental Health Subcommittee of PTAC meeting held 21 June (minutes for web publishing)

Mental Health Subcommittee of PTAC meeting held 21 June (minutes for web publishing) Mental Health Subcommittee of PTAC meeting held 21 June 2010 (minutes for web publishing) Mental Health Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology

More information

NICE Clinical Guidelines recommending Family and Couple Therapy

NICE Clinical Guidelines recommending Family and Couple Therapy Association for Family Therapy and Systemic Practice NICE Clinical Guidelines recommending Family and Couple Therapy August 2016 Compiled by: Dr Lucy Davis (Chartered and Clinical Psychologist/Trainee

More information

Some Common Mental Disorders in Young People Module 3B

Some Common Mental Disorders in Young People Module 3B Some Common Mental Disorders in Young People Module 3B MENTAL ILLNESS AND TEENS About 70% of all mental illnesses can be diagnosed before 25 years of age When they start, most mental illnesses are mild

More information

Table 1: Salford Royal NHS Foundation Trust: Performance in initiating clinical research: Reporting period 1 April March 2014

Table 1: Salford Royal NHS Foundation Trust: Performance in initiating clinical research: Reporting period 1 April March 2014 Table 1: Salford Royal NHS Foundation Trust: Performance in initiating clinical research: Reporting period 1 April 2013-31 March 2014 Research Ethics Committee Name of Trial reference number 1 08/H0906/140

More information

Dementia: Rethinking our approach to behaviour

Dementia: Rethinking our approach to behaviour Dementia: Rethinking our approach to behaviour Dr Kathryn Lord Research Fellow 1 A bit about me: The 3 P s! Psychology Psychiatry Person centredcare 2 Challenging behaviours in Challenging behaviours dementia

More information

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric

More information

U.S. 1 February 22, 2013

U.S. 1 February 22, 2013 U.S. 1 February 22, 2013 A Placebo-controlled, Randomized, Blinded, Dose Finding Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults Study Code: MAA-1 Sponsor: Multidisciplinary

More information

-Guidelines for the discontinuation of oral antipsychotics in patients with BPSD within the primary care setting Summary- Quetiapine

-Guidelines for the discontinuation of oral antipsychotics in patients with BPSD within the primary care setting Summary- Quetiapine -Guidelines for the discontinuation of oral antipsychotics in patients with BPSD within the primary care setting Summary- Quetiapine An independent report Time for action 1 by Professor Sube Banerjee looked

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Single Technology Appraisal Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar disorder in children and adolescents

More information

Recent Advances in the Antipsychotic Treatment of People with schizophrenia. Robert W. Buchanan, M.D.

Recent Advances in the Antipsychotic Treatment of People with schizophrenia. Robert W. Buchanan, M.D. Recent Advances in the Antipsychotic Treatment of People with schizophrenia Robert W. Buchanan, M.D. Antipsychotic medications are the primary class of drugs used in the pharmacological treatment of schizophrenia.

More information

Pediatric Psychopharmacology

Pediatric Psychopharmacology Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders

More information

Table of Contents. 1.0 Policy Statement...1

Table of Contents. 1.0 Policy Statement...1 Division of Medical Assistance General Clinical Policy No. A-6 Table of Contents 1.0 Policy Statement...1 2.0 Policy Guidelines...1 2.1 Eligible Recipients...1 2.1.1 General Provisions...1 2.1.2 EPSDT

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Psychosis and schizophrenia in children and young people: recognition and management 1.1 Short title Psychosis and schizophrenia

More information

Resources for carers. Additional information resources you may find helpful in your caring role

Resources for carers. Additional information resources you may find helpful in your caring role Resources for carers Additional information resources you may find helpful in your caring role 1 The publications listed in this booklet can provide you with additional information about the person you

More information

National Academy of Science July 17-18, 2018 Washington DC Larry Alphs, MD, PhD RESTRICTION OF TREATMENT QUALITY IN PRAGMATIC CLINICAL TRIALS

National Academy of Science July 17-18, 2018 Washington DC Larry Alphs, MD, PhD RESTRICTION OF TREATMENT QUALITY IN PRAGMATIC CLINICAL TRIALS National Academy of Science July 17-18, 2018 Washington DC Larry Alphs, MD, PhD RESTRICTION OF TREATMENT QUALITY IN PRAGMATIC CLINICAL TRIALS Key Points for RWE in Randomized Clinical Trials What is the

More information

Open Translational Science in Schizophrenia. Harvard Catalyst Workshop March 24, 2015

Open Translational Science in Schizophrenia. Harvard Catalyst Workshop March 24, 2015 Open Translational Science in Schizophrenia Harvard Catalyst Workshop March 24, 2015 1 Fostering Use of the Janssen Clinical Trial Data The goal of this project is to foster collaborations around Janssen

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

Table 1: Salford Royal NHS Foundation Trust: Performance in initiating clinical research: Reporting period 1 October September 2013

Table 1: Salford Royal NHS Foundation Trust: Performance in initiating clinical research: Reporting period 1 October September 2013 Table 1: Salford Royal NHS Foundation Trust: Performance in initiating clinical research: Reporting period 1 October 2012-30 September 2013 Research Ethics Committee reference number Name of Trial 1 12/NW/0321

More information

The Place for Treatments of Associated Neuropsychiatric and Other Symptoms in Alzheimer s Disease and Other Dementias

The Place for Treatments of Associated Neuropsychiatric and Other Symptoms in Alzheimer s Disease and Other Dementias The Place for Treatments of Associated Neuropsychiatric and Other Symptoms in Alzheimer s Disease and Other Dementias The Patient and Carers Perspective Mary-Frances Morris, Trustee, Alzheimer Scotland.

More information

Mental Health Futures event.

Mental Health Futures event. Mental Health Futures event. Dr Stuart Adams, Consultant Psychiatrist and Clinical Director for Merton and Sutton Gill Moore, Operational Manager, Sutton and Merton Adult Services Dr Hendrik Hinrichsen,

More information

PRESCRIBING GUIDELINES

PRESCRIBING GUIDELINES The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors

More information

Class Update: Oral Antipsychotics

Class Update: Oral Antipsychotics Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole

Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole University of Wollongong Research Online Faculty of Science, Medicine and Health - Papers Faculty of Science, Medicine and Health 2010 Potential control of antipsychotic-induced hyperprolactinemia and

More information

Taking Care: Child and Youth Mental Health PSYCHOSIS TREATMENT OPTIONS

Taking Care: Child and Youth Mental Health PSYCHOSIS TREATMENT OPTIONS Taking Care: Child and Youth Mental Health PSYCHOSIS TREATMENT OPTIONS Open Learning Agency 2004 TREATMENT OPTIONS Psychosis is highly treatable, especially if caught early. The prognosis for recovery

More information

Curriculum Vitae, Glenn Michael Dempsey, M.D.

Curriculum Vitae, Glenn Michael Dempsey, M.D. CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Alliance Director Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com Glenn Michael Dempsey, M.D. Albuquerque

More information

Curriculum Vitae, Glenn Michael Dempsey, M.D.

Curriculum Vitae, Glenn Michael Dempsey, M.D. CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Alliance Director Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com EDUCATION: Glenn Michael Dempsey,

More information

Curriculum Vitae, Haig Armen Goenjian, M.D. Haig Armen Goenjian, M.D. Collaborative Neuroscience Network, LLC

Curriculum Vitae, Haig Armen Goenjian, M.D. Haig Armen Goenjian, M.D. Collaborative Neuroscience Network, LLC CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Alliance Director Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com AFFILIATIONS: Collaborative Neuroscience

More information

Contemporary Psychiatric-Mental Health Nursing. Features of Schizophrenia. Features of Schizophrenia - continued

Contemporary Psychiatric-Mental Health Nursing. Features of Schizophrenia. Features of Schizophrenia - continued Contemporary Psychiatric-Mental Health Nursing Chapter 16 Schizophrenia and Other Psychotic Disorders Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties,

More information

JOHNNA L. KEEN, MSW, LCSW

JOHNNA L. KEEN, MSW, LCSW JOHNNA L. KEEN, MSW, LCSW EDUCATION Degree Concentration Year Institution M.S.W. Direct Practice 1994 Rutgers University B.A. Psychology 1988 Rowan University EXPERIENCE Year Position Location 2011-Present

More information

Hope FIRST: An Innovative Treatment for First Episode Psychosis PRESENTATION BY REBECCA FLATTERY, LCSW AND BRIAN ROHLOFF, LPC

Hope FIRST: An Innovative Treatment for First Episode Psychosis PRESENTATION BY REBECCA FLATTERY, LCSW AND BRIAN ROHLOFF, LPC Hope FIRST: An Innovative Treatment for First Episode Psychosis PRESENTATION BY REBECCA FLATTERY, LCSW AND BRIAN ROHLOFF, LPC What is a first episode of psychosis? The word psychosis is used to describe

More information

Behavioral and Psychological Symptoms of dementia (BPSD)

Behavioral and Psychological Symptoms of dementia (BPSD) Behavioral and Psychological Symptoms of dementia (BPSD) Chris Collins - Old Age Psychiatrist, Christchurch chris.collins@cdhb.health.nz Approaching BPSD: the right mindset Assessment Non-drug management

More information

Intro to Concurrent Disorders

Intro to Concurrent Disorders CSAM-SCAM Fundamentals Intro to Concurrent Disorders Presentation provided by Jennifer Brasch, MD, FRCPC Psychiatrist, Concurrent Disorders Program, St. Joseph s Healthcare There are all kinds of addicts,

More information

Referral guidance for Lincolnshire CAMHS

Referral guidance for Lincolnshire CAMHS Referral guidance for Lincolnshire CAMHS The service is designed to meet a wide range of mental health needs in children and young people. This includes mild to moderate emotional wellbeing and mental

More information

Mental Health Strategy. Easy Read

Mental Health Strategy. Easy Read Mental Health Strategy Easy Read Mental Health Strategy Easy Read The Scottish Government, Edinburgh 2012 Crown copyright 2012 You may re-use this information (excluding logos and images) free of charge

More information

8/23/2016. Chapter 34. Care of the Patient with a Psychiatric Disorder. Care of the Patient with a Psychiatric Disorder

8/23/2016. Chapter 34. Care of the Patient with a Psychiatric Disorder. Care of the Patient with a Psychiatric Disorder Chapter 34 Care of the Patient with a Psychiatric Disorder All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Care of the Patient with a Psychiatric

More information

Appendix N: Research recommendations

Appendix N: Research recommendations Appendix N: recommendations N.1 First-line treatment of motor symptoms recommendation 1 Interventions What is the effectiveness of initial levodopa monotherapy versus initial levodopa-dopamine agonist

More information

Howard A. Hassman, D.O. Hassman Research Institute, LLC. 175 Cross Keys Road Centennial Center, Bldg. 300 B Berlin, NJ 08009

Howard A. Hassman, D.O. Hassman Research Institute, LLC. 175 Cross Keys Road Centennial Center, Bldg. 300 B Berlin, NJ 08009 CONTACT INFORMATION: Howard A. Hassman, D.O. Hassman Research Institute, LLC. 175 Cross Keys Road Centennial Center, Bldg. 300 B Berlin, NJ 08009 Site Selection and Information: Bobbie Theodore, Alliance

More information

CAMHS - Childrens Scrutiny Panel Rutland Adam McKeown Head of FYPC Group 1 & Adult LD.

CAMHS - Childrens Scrutiny Panel Rutland Adam McKeown Head of FYPC Group 1 & Adult LD. CAMHS - Childrens Scrutiny Panel Rutland Adam McKeown Head of FYPC Group 1 & Adult LD www.leicspart.nhs.uk Contents Overview of CAMHS Services provided by LPT Current overall CAMHS performance context

More information

CUA. THE CATHOLIC UNIVERSITY OF AMERICA National Catholic School of Social Service Shahan Hall Washington, DC Fax

CUA. THE CATHOLIC UNIVERSITY OF AMERICA National Catholic School of Social Service Shahan Hall Washington, DC Fax 1 CUA THE CATHOLIC UNIVERSITY OF AMERICA National Catholic School of Social Service Shahan Hall Washington, DC 20064 202-319-5458 Fax 202-319-5093 SSS 572 Human Development and Psychopathology Spring 2009

More information

4/29/2016. Psychosis A final common pathway. Early Intervention in Psychotic Disorders: Necessary, Effective, and Overdue

4/29/2016. Psychosis A final common pathway. Early Intervention in Psychotic Disorders: Necessary, Effective, and Overdue Early Intervention in Psychotic Disorders: Necessary, Effective, and Overdue Disclosures Financial relationships with commercial interests Douglas R. Robbins, M.D. Maine Medical Center Tufts University

More information

Agitation in dementia. Gill Livingston

Agitation in dementia. Gill Livingston Agitation in dementia Gill Livingston And some of the team Gianluca Baio Julie Barber Claudia Cooper Briony Dow Paul Higgs Juanita Hoe Gerry Leavey Louise Marston Stephen Morris Rumana Omar Nishma Patel

More information

296, /11/ /10/2018 Project: Research Research Contract

296, /11/ /10/2018 Project: Research Research Contract Projects Listing of Projects Closing the treatment gap in anorexia nervosa Brain and Behavior Research Foundation Kan, C.,, Lewis, C. 24,471.09 15/01/2019 14/01/2020 An investigation to examine the feasibility

More information

Curriculum Vitae, Glenn Michael Dempsey, M.D.

Curriculum Vitae, Glenn Michael Dempsey, M.D. CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Alliance Director Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com EDUCATION: Glenn Michael Dempsey,

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Psychosis and schizophrenia in adults: treatment and management Quality standard title:

More information

Surveillance report Published: 26 October 2017 nice.org.uk

Surveillance report Published: 26 October 2017 nice.org.uk Surveillance report 2017 Bipolar disorder: assessment and management (2014) NICE guideline Surveillance report Published: 26 October 2017 nice.org.uk NICE 2017. All rights reserved. Subject to Notice of

More information

Dr Keith Ganasen Department of Psychiatry UCT

Dr Keith Ganasen Department of Psychiatry UCT Dr Keith Ganasen Department of Psychiatry UCT A. Significantly subaverage intellectual functioning: an IQ of approximately 70 or below on an individually administered IQ test B. Concurrent deficits or

More information

A Framework for improving the experience of autistic adults using TEWV Services. MARCH 2018

A Framework for improving the experience of autistic adults using TEWV Services. MARCH 2018 A Framework for improving the experience of autistic adults using TEWV Services. MARCH 2018 Why does TEWV need an autism framework? Autism is more common than a lot of us think. It affects around one in

More information

Legend. Innovations in Treatment and Recovery. Industry Symposia Oral Communications E Short Communications SUNDAY FEBRUARY 25, 2018

Legend. Innovations in Treatment and Recovery. Industry Symposia Oral Communications E Short Communications SUNDAY FEBRUARY 25, 2018 Legend Plenary Innovations in Neuroscience Innovations in Treatment and Recovery Innovations in Thinking Innovations in Technologies Innovations in Policy and Planning Health Industry Symposia Oral Communications

More information

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Effective: July. 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy

More information

Table 1 Salford Royal NHS Foundation Trust: Performance in initiating clinical research (HRA Approval) Reporting period 1 April March 2017

Table 1 Salford Royal NHS Foundation Trust: Performance in initiating clinical research (HRA Approval) Reporting period 1 April March 2017 Table 1 Salford Royal NHS Foundation Trust: Performance in initiating clinical research (HRA Approval) Reporting period 1 April 2016 31 March 2017 REC reference IRAS number Study title 16/NW/0428 207062

More information

A17/B17: Delirium Can Be Deadly: Save Lives With a Standardized Approach to Delirium IHI 25th Annual National Forum, December 10, 2013

A17/B17: Delirium Can Be Deadly: Save Lives With a Standardized Approach to Delirium IHI 25th Annual National Forum, December 10, 2013 A17/B17: Delirium Can Be Deadly: Save Lives With a Standardized Approach to Delirium IHI 25th Annual National Forum, December 10, 2013 Clay Angel, MD, Hospital Medicine; Chief of Continuum/SNF Kristen

More information

MODEL PSYCHOPHARMACOLOGY CURRICULUM

MODEL PSYCHOPHARMACOLOGY CURRICULUM Third Edition MODEL PSYCHOPHARMACOLOGY CURRICULUM For Psychiatric Residency Programs, Training Directors and Teachers of Psychopharmacology VOLUME I By A Committee of the American Society of Clinical Psychopharmacology

More information

Sleep, the clock and mental health. Dr Kate Porcheret Sleep and Circadian Neuroscience Institute University of Oxford

Sleep, the clock and mental health. Dr Kate Porcheret Sleep and Circadian Neuroscience Institute University of Oxford Sleep, the clock and mental health Dr Kate Porcheret Sleep and Circadian Neuroscience Institute University of Oxford Sleep is fundamental We spend 1/3 of our lives asleep Source: Bureau of Labor Statistics,

More information